Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka
Objectives To study if early initiation of inhaled beclomethasone 1200 mcg in patients with asymptomatic, mild or moderate COVID-19 reduces disease progression to severe COVID-19.Design Double-blinded, parallel-groups, randomised, placebo-controlled trial.Setting A hospital-based study in Sri Lanka....
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2023-12-01
|
| シリーズ: | BMJ Open |
| オンライン･アクセス: | https://bmjopen.bmj.com/content/13/12/e075803.full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|